Agilent Technologies (USA)
Charmion Cruickshank-Quinn is from the Eastern Caribbean island of Dominica. She is an enthusiastic scientist whose background is in lung disease research, omics integration, and biomarker discovery, using LCMS-based metabolomics.
She received her BS in Chemistry from the State University of New York (SUNY) at Albany and her PhD in Chemistry from SUNY Buffalo. As part of her doctoral project, she performed method development for profiling biological samples to determine markers of oxidative stress and autism.
Charmion then pursued a Postdoctoral fellowship at National Jewish Health followed by a position as Instructor at the University of Colorado Denver|Anschutz working in the laboratory of Dr. Nichole Reisdorph. She performed targeted and untargeted liquid chromatography mass spectrometry-based metabolomics for asthma and chronic obstructive pulmonary disease projects. She also worked towards understanding the biological effects of cigarette smoking on a healthy metabolome using an emphysema mouse model, and determining parallels between mouse and human data for translation studies. Her other contribution to metabolomics involves taking a systems biology approach by integrating functional genomics and metabolomics data. Charmion recently accepted a position with Agilent Technologies as an Applications Scientist where she consults with clients nationwide on their LCMS-based projects.
Charmion has been active in the Metabolomics Society for the past two years where she was a member of the EMN Committee from 2016-2017, and currently serves as Chair for 2017-2018.